Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Where Regeneron Pharmaceuticals Stands With Analysts

Analysts have provided the following ratings for Regeneron Pharmaceuticals (NASDAQ:REGN) within the last quarter:

3 High-Quality Stocks to Buy During This Market Selloff

3 High-Quality Stocks to Buy During This Market Selloff

The near-term market outlook remains cloudy. While the S&P 500 is about 3% above its late-February lows, the Nasdaq and Russell 2000 have already undercut these levels. Below are 3 such stocks that investors should consider buying during this market correction: Anthem (ANTM), Pfizer (PFE), and Builders FirstSource (BLDR).

How Expedia Group Stock Looks Heading Into Q1 Earnings Print

How Expedia Group Stock Looks Heading Into Q1 Earnings Print

Expedia Group, Inc (NASDAQ: EXPE) is set to print its first-quarter financial results after the market close. The stock was trading slightly lower heading into the event and remains down over 20% from the Feb. 16 all-time high of $217.72.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Here's Why This Analyst Cut Price Target On Regeneron

RBC Capital Markets has lowered Regeneron Pharmaceuticals Inc's price target (NASDAQ:REGN) from $679 to $647 and maintained a Sector Perform rating. Checks suggest that Dupixent (dupilumab) growth/durability should remain strong in new and existing indications, maintaining positive sentiment. The analysts also believe that the concerns about near-term Eylea competition may be overblown. However, high-dose…

Why RBC Capital Sees 'Multiple High-Risk' On This Neurology-Focused Stock

RBC Capital Markets writes that Prothena Corporation plc (NASDAQ: PRTA) believes that the recent stock downside provides an entry point and that progress with the programs and improved sentiment in the space could drive appreciation.

Mid-Afternoon Market Update: Nasdaq Gains 100 Points; First Wave BioPharma Shares Plunge

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 100 points on Monday.

12 Information Technology Stocks Moving In Monday's Intraday Session

inkl

Read news from The Economist, FT, and more,
with one subscription

12 Industrials Stocks Moving In Monday's Intraday Session

12 Industrials Stocks Moving In Monday's Intraday Session

10 Consumer Discretionary Stocks Moving In Monday's Intraday Session

10 Consumer Discretionary Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Monday's Intraday Session

Kopin's Earnings Outlook

Kopin's Earnings Outlook

Kopin (NASDAQ:KOPN) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Kopin will report an earnings per share (EPS) of $-0.03.

A Preview Of Lindblad Expeditions's Earnings

A Preview Of Lindblad Expeditions's Earnings

Lindblad Expeditions (NASDAQ:LIND) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Lindblad Expeditions will report an earnings per share (EPS) of $-0.60.

Where Array Technologies Stands With Analysts

Where Array Technologies Stands With Analysts

Within the last quarter, Array Technologies (NASDAQ:ARRY) has observed the following analyst ratings:

Macrogenics's Earnings Outlook

Macrogenics's Earnings Outlook

Macrogenics (NASDAQ:MGNX) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Macrogenics will report an earnings per share (EPS) of $-0.86.

Get all your
news in one place.

100's of premium titles.
One news app.

Expert Ratings for Sunrun

Analysts have provided the following ratings for Sunrun (NASDAQ:RUN) within the last quarter:

Earnings Outlook For Monroe Capital

Monroe Capital (NASDAQ:MRCC) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Monroe Capital will report an earnings per share (EPS) of $0.25.

Lantern Pharma Earnings Preview

Lantern Pharma (NASDAQ:LTRN) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Lantern Pharma will report an earnings per share (EPS) of $-0.29.

Earnings Outlook For MiMedx Group

MiMedx Group (NASDAQ:MDXG) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that MiMedx Group will report an earnings per share (EPS) of $-0.10.

Get all your
news in one place.

100's of premium titles.
One news app.

Earnings Outlook For Landsea Homes

Landsea Homes (NASDAQ:LSEA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Landsea Homes will report an earnings per share (EPS) of $0.24.

Earnings Outlook For AppHarvest

AppHarvest (NASDAQ:APPH) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that AppHarvest will report an earnings per share (EPS) of $-0.33.

This Investor Is Shaking Up Exposure To Apple, Amazon And Meta: Here's What He's Buying And Selling

Amid recent volatility in the FAANG names, Virtus Investment Partners' Joe Terranova is shaking up his portfolio.

$1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 5 years by 6.39% on an annualized basis producing an average annual return of 17.51%. Currently, Vertex Pharmaceuticals has a market capitalization of $65.74 billion.

Expert Ratings for Lumentum Holdings

Over the past 3 months, 9 analysts have published their opinion on Lumentum Holdings (NASDAQ:LITE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Red Rock Resorts Earnings Preview

Red Rock Resorts (NASDAQ:RRR) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Red Rock Resorts will report an earnings per share (EPS) of $0.66.

Earnings Outlook For Aquestive Therapeutics

Aquestive Therapeutics (NASDAQ:AQST) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Aquestive Therapeutics will report an earnings per share (EPS) of $-0.41.

1 … 642 643 644 645

People

Jaimini DesaiJaimini Desai

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Spirit Airlines

RBC Capital Markets

Regeneron Pharmaceuticals

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play